Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 10;10(2):267.
doi: 10.3390/vaccines10020267.

Duration of Hepatitis B Vaccine-Induced Protection among Medical Students and Healthcare Workers following Primary Vaccination in Infancy and Rate of Immunity Decline

Nanthida Phattraprayoon  1 , Jirapa Kakheaw  2 , Kamonwan Soonklang  3 , Kunsuda Cheirsilpa  2 , Teerapat Ungtrakul  1 , Chirayu Auewarakul  1 , Nithi Mahanonda  2
Affiliations

Duration of Hepatitis B Vaccine-Induced Protection among Medical Students and Healthcare Workers following Primary Vaccination in Infancy and Rate of Immunity Decline

Nanthida Phattraprayoon et al. Vaccines (Basel). .

Abstract

Since the introduction of hepatitis B virus (HBV) vaccines, the numbers of HBV infections and complications have significantly decreased. However, the evidence on whether primary vaccination of infants confers lifelong immunity varies. We aimed to assess long-term immunity among healthcare workers and medical students, and the rate of decline of HBV surface antigen antibodies (anti-HBs). Hepatitis B status among participants born after 1 January 1992 was reviewed at Chulabhorn Royal Academy, Thailand. Participants were stratified by intervals since primary vaccination. HBV immunity was determined and analyzed as anti-HBs decline rate in participants with multiple follow-ups. A total of 464 participants were analyzed, with a median age of 23. Protective immunity against HBV (anti-HBs ≥ 10 mIU/mL) at 16-20, 21-25 and 26-28 years post-primary vaccination was 28%, 51.7% and 60%, respectively. The overall declining rate of anti-HBs was -42.39 mIU/mL per year. Participants with anti-HBs levels of >100-1000 mIU/mL at baseline had a faster decline rate than those with anti-HBs levels of 10-100 mIU/mL. Primary vaccination may not provide lifelong protection since HBV immunity deteriorates over time. Individuals with higher initial HBV immunity levels may experience a faster decline rate.

Keywords: healthcare workers; hepatitis B; primary vaccination; rate of immunity decline.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

Figure 1
Figure 1
Rate of decline of anti-HBs using mixed-model regression analysis. (a) Anti-HBs 10–1000 mIU/mL, (b) anti-HBs 10–100 mIU/mL, (c) anti-HBs > 100–1000 mIU/mL.
See this image and copyright information in PMC

References

    1. Hepatitis B Fact Sheet. [(accessed on 1 December 2021)]. Available online: http://www.who.int/mediacentre/factsheets/fs204/en/
    1. MacLachlan J.H., Locarnini S., Cowie B.C. Estimating the global prevalence of hepatitis B. Lancet. 2015;386:1515–1517. doi: 10.1016/S0140-6736(15)61116-3. - DOI - PubMed
    1. Guidelines for Viral Hepatitis Surveillance and Case Management. [(accessed on 1 December 2021)]; Available online: https://www.cdc.gov/hepatitis/statistics/surveillanceguidelines.htm.
    1. Thailand’s Achievement on Hepatitis B Control. [(accessed on 1 December 2021)]. Available online: https://www.who.int/thailand/news/detail/08-08-2019-thailand-achievement....
    1. WHO Hepatitis B Report, 2017. Executive Summary. [(accessed on 1 December 2021)]. Available online: https://www.who.int/publications/i/item/global-hepatitis-report-2017.

LinkOut - more resources